To test our hypothesis that NCK1-AS1 expression is dysregulated in ESCC and this dysregulation carries important clinical significance, we determined its levels in ESCC tissues, paired non-tumor tissues, and plasma of ESCC patients and analyzed their relationship. This evidence concerns the gene NCK1 and esophageal squamous cell carcinoma.